Beneficial Effects of Chronic Therapy with Tolvaptan, a Novel Vasopressin Receptor Blocker, in Patients with Congestive Heart Failure
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2002-03-31
著者
-
Kambayashi Jun-ichi
Otsuka Maryland Research Institute
-
Orlandi Cesare
Otsuka Maryland Research Institute
-
Ouyang John
Otsuka Maryland Research Institute
-
Konstam Marvin
Tufts University Medical School
-
Gheorghiade Mihai
Northwestern University
-
Konstam Marvin
Tufts Medical Center
-
KAMBAYASHI Jun-ichi
Otsuka America Pharmaceutical Inc., Maryland Research Laboratories
関連論文
- A Unique Method of Closure for an Aortocaval Fistula in Association with a Ruptured Abdominal Aortic Aneurysm : Report of a Case
- Beneficial Effects of Chronic Therapy with Tolvaptan, a Novel Vasopressin Receptor Blocker, in Patients with Congestive Heart Failure
- Heart Failure : A Cardio-renal-vascular Syndrome(Special Lecture 13,The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- "Diastolic Dysfunction" in Heart Failure : Is it Time for a New Paradigm?(Clinical Aspects of Diastolic Failure, The 69th Annual Scientific Meeting of the Japanese Circulation Society)